Isolation and Characterization of Secondary Metabolites from Hydractinia-Associated Fungus, Penicillium brevicompactum MSW10-1, and Their Inhibitory Effects on Hepatic Lipogenesis
Marine Drugs · 2025
DOI: 10.3390/md23070275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Hyeon-Jeong Hwang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Penicillium, Lipogenesis, Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Basic Science Institute.
Abstract (Originalsprache)
Marine organism-associated microbes are an important source of structurally diverse and biologically active secondary metabolites exhibiting antimicrobial, anticancer, and anti-inflammatory activities. In this study, we investigated Penicillium brevicompactum MSW10-1, isolated from Hydractinia echinata, a marine invertebrate adapted to extreme intertidal and subtidal environments with variable temperature, salinity, and oxygen conditions. Through a combination of LC/MS-guided chemical analysis and chromatographic purification, eight secondary metabolites were isolated, including brevicolactones A (1) and B (2). The absolute chemical structures of 1 and 2 were determined based on NMR spectroscopic experiments, HR-ESIMS data, and quantum chemical ECD calculations. The isolated compounds (1–8) were evaluated for their ability to inhibit hepatic lipogenesis, a key process in lipid metabolism that is dysregulated in metabolic-dysfunction-associated steatotic liver disease. Furthermore, the inhibitory effects of the isolated compounds on lipid accumulation were further evaluated in primary mouse hepatocytes, using Oil Red O staining. These findings suggested that the isolated compounds may serve as promising candidates for the treatment of metabolic liver diseases associated with lipid dysregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea.
- Department of Integrative Biological Sciences and Industry, Sejong University, Seoul 05006, Republic of Korea.
ORCID-Profile: Jae Sik Yu, Seonghwan Hwang, Seoung Rak Lee
Förderung
- National Research Foundation of Korea
- Korea Basic Science Institute
Zitieren
APA
Hwang, H. J., Lim, H., Yu, J. S., Jang, E. S., Nam, Y., Lee, Y. J., Kim, E., Hwang, S., & Lee, S. R. (2025). Isolation and Characterization of Secondary Metabolites from Hydractinia-Associated Fungus, Penicillium brevicompactum MSW10-1, and Their Inhibitory Effects on Hepatic Lipogenesis. Marine Drugs. https://doi.org/10.3390/md23070275
Vancouver
Hwang HJ, Lim H, Yu JS, Jang ES, Nam Y, Lee YJ, et al. Isolation and Characterization of Secondary Metabolites from Hydractinia-Associated Fungus, Penicillium brevicompactum MSW10-1, and Their Inhibitory Effects on Hepatic Lipogenesis. Marine Drugs. 2025. doi:10.3390/md23070275
BibTeX
@article{Hwang2025,
author = {Hwang, Hyeon-Jeong and Lim, Hyeokjin and Yu, Jae Sik and Jang, Eun Seo and Nam, Youngsang and Lee, Yeo Jin and Kim, Eun La and Hwang, Seonghwan and Lee, Seoung Rak},
title = {Isolation and Characterization of Secondary Metabolites from Hydractinia-Associated Fungus, Penicillium brevicompactum MSW10-1, and Their Inhibitory Effects on Hepatic Lipogenesis},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23070275}
}
EUVIMED